Chemical Structure : AC-4-130
CAS No.: 1834571-82-2
Catalog No.: PC-62556Not For Human Use, Lab Use Only.
AC-4-130 is a novel, potent STAT5 SH2 domain inhibitor, binds to and efficiently blocks STAT5 activation and subsequent transcriptional activity, shows high selectivity for STAT5 over STAT1 and STAT3.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $198 | In stock | |
10 mg | $298 | In stock | |
25 mg | $488 | In stock | |
50 mg | $778 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
AC-4-130 is a novel, potent STAT5 SH2 domain inhibitor, binds to and efficiently blocks STAT5 activation and subsequent transcriptional activity, shows high selectivity for STAT5 over STAT1 and STAT3.
AC-4-130 disrupts STAT5 activation, dimerization, nuclear translocation, and STAT5-dependent gene transcription.
AC-4-130 substantially impairs the proliferation and clonogenic growth of human AML cell lines and primary FLT3-ITD+ AML patient cells in vitro and in vivo.
AC-4-130 synergistically increases the cytotoxicity of the JAK1/2 inhibitor Ruxolitinib and the p300/pCAF inhibitor Garcinol in vivo.
M.Wt | 751.206 | |
Formula | C37H36ClF5N2O5S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
4-(2-((N-(4-chlorobenzyl)-2,3,4,5,6-pentafluorophenyl)sulfonamido)-N-(3,5-di-tert-butylbenzyl)acetamido)benzoic acid |
1. Wingelhofer B, et al. Leukemia. 2018 Feb 2. doi: 10.1038/s41375-017-0005-9.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright